Showing results (91-100 of 202) with videos related to
Sort By:
Pageof 21
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1988
Binding and functional characterization of the cardioselective muscarinic antagonist methoctramineE Giraldo, R Micheletti, E Montagna, et al.Cancer|December 1, 1993
A phase II study of mitoxantrone combined with beta-interferon in unresectable hepatocellular carcinomaM Colleoni, R Buzzoni, E Bajetta, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1993
Effective salvage chemotherapy in relapsed or refractory non-Hodgkin's lymphomaR Buzzoni, M Colleoni, E Bajetta, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 27, 2007
Management of advanced breast cancerL Orlando, M Colleoni, P Fedele, et al.Oncology Reports|May 19, 2011
Cisplatin, etoposide and bleomycin infusion (PEBi regimen) in good-risk patients with germ cell tumorsM Colleoni, R Graffeo, G Martinelli, et al.Oncology Reports|May 19, 2011
Prognostic factors in patients with hepatocellular carcinoma submitted to chemoembolizationM Colleoni, G Liessi, G Mastrapasqua, et al.Oncology Reports|May 21, 2011
Phase-ii trial of oral doxifluridine plus oral levo-leucovorin in unresectable hepatocellular-carcinomaM Colleoni, M Dibartolomeo, E Bajetta, et al.Tumori|January 16, 1998
Mitomycin C and vinorelbine in pretreated breast cancerM Colleoni, P Manente, J Stocker, et al.Oncology Reports|May 20, 2011
Pleurectomy, intrapleural cisplatin and interferon followed by systemic carboplatin plus interferon in malignant pleural mesotheliomaM Colleoni, F Sartori, F Calabro, et al.European Journal of Pharmacology|October 15, 1991
Pharmacological properties of a novel class of 5-HT3 receptor antagonistsM Turconi, A Donetti, A Schiavone, et al.Pageof 21